The Past, Present and Future of Mobile Visits in Decentralized Clinical Trials:

Industry thought leaders imagine how mobile visits should evolve to meet the challenges of tomorrow.

23

January

  • 10:00 am Eastern time
  • Free

Why attend?

In this open and engaging discussion, we hear from DCT industry veterans about how far we’ve come in incorporating mobile visits into decentralized clinical trials. Craig Lipset will share his early days at Pfizer at the dawn of the DCT movement and his early support of the model, and the challenges and barriers he faced. Deb will then report on her role and responsibilities working with teams to effectively incorporate mobile visits into study protocols. Then, together with facilitator Ellen Weiss, the group will imagine the future of mobile research and how it evolves within the DCT ecosystem.

Attendees will:

  • Learn the genesis and evolution of the DCT movement!
  • Compare past successes and challenges with successes and challenges of today.
  • Understand the value of DCTs in today’s research landscape.

Speakers

Select a speaker to learn more

Back
Ellen Weiss
VP, In-Home Solutions, DCT, PCM Trials

Ellen Weiss connects CROs and sponsors with right-sized hybrid and remote solutions. She has spoken on the logistical support necessary for IMP delivery and dosing, sample collection, and the services provided by clinical trial research nurses that enable alternate-site visits to be carried out with the same data quality and subject safety as on-site visits. Ellen is a member of the Healthcare Businesswomen’s Association and a volunteer for the American Society of Clinical Oncology.

Next speaker
Back
Next speaker
Back
Deb Guattery
Standards and Process Lead, Decentralized Clinical Trials at Pfizer

Deb Guattery most recently worked at Pfizer as the Process Lead for Home Health and Decentralized Clinical Trials. In that role, she built the processes and expanded the services of home nursing visits and other decentralized trial elements to be written into clinical trial protocols. Deb also advised in the writing of WCG Avoca Key Performance Indicators for the use of home health visits in a clinical trial and is an active participant in collaborative groups within the Decentralized Trials and Research Alliance (DTRA).

Deb continues to seek the advance of decentralized elements like the use of home health visits with the ultimate goal of driving better recruitment and retention of more diverse patients in clinical trials.

Next speaker

Enquiry